Navigation Links
New Data Confirm That Use of Levemir Can Limit Weight Gain

lin detemir used in basal-bolus therapy in people with type 1 diabetes is associated with a lower risk of nocturnal hypoglycaemia and less weight gain over 12 months in comparison to NPH insulin. Diabetes Obes Metab 2005; 7(1):73–82

16 Pieber T et al. Comparison of three multiple injection regimens for Type 1 diabetes: morning plus dinner or bedtime administration of insulin detemir vs. morning plus bedtime NPH insulin. Diabetic Medicine 2005; 22(7):850–57

17 Standl E et al. The 12-month efficacy and safety of insulin detemir and NPH insulin in basal-bolus therapy for the treatment of type 1 diabetes. Diabetes Technology Therapeutics 2004; 6(5):579–88

18 Home P et al. Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes: a randomized clinical trial. Diabetes Care 2004; 27(5):1081–87

19 Hermansen K et al. Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal bolus therapy for patients with type 1 diabetes. Diabetologia 2004; 47(4):622–29

20 Rašlova K et al. Insulin detemir and insulin aspart: a promising basal-bolus regimen for type 2 diabetes. Diabetes Res Clin Pract 2004; 66(2):193–201

21 Haak T et al. Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes. Diabetes Obes Metab 2005; 7(1):56–64

22 Robertson K et al. Insulin detemir compared with NPH insulin in children and adolescent with type 1 diabetes, Diabetes Medicine 2007; 24(1):27

23 Pieber TR et al. Insulin detemir plus insulin aspart is associated with less risk of major as well as nocturnal hypoglycaemia than insulin glargine plus insulin aspart at comparable levels of glycaemic control in type 1 diabetes. Diabetic Medicine 2007. In press.

24 Klein O et al. A
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
2. YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
3. Publication Confirms that EpCAM, the Target for Two of Micromets Product Candidates, Is Overexpressed on Cancer Stem Cells of Certain Cancers
4. MediQuest Concludes Confirmatory Phase III Study of Raynaud’s Therapy
5. New Data Confirms Significant Improvement of Disease Signs and Symptoms in Patients with Rheumatoid Arthritis
6. Encouraging Clinical Activity of GSKs Novel Cancer Immunotherapeutic Confirmed in Phase II Study in Patients with Most Common Form of Lung Cancer
7. New Research Confirms the Benefit of Extended-Release Dipyridamole Plus ASA for Preventing Recurrent Stroke in Low- and High-Risk Patients
8. New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release Tablets as Effective Treatment for Schizophrenia
9. Positive Clinical Data on CC-10004 Confirms Potential as Novel Oral Approach to Treating Inflammatory Diseases
10. Independent Publication Confirms Growing Therapeutic Challenge of T315I Mutation in Patients with CML, Notes ChemGenex
11. Efficacy and Safety Profile of Basileas Alitretinoin for Severe Refractory Chronic Hand Eczema Confirmed by Data Shown at European Dermatology Congress
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Data Confirm That Use Levemir Can Limit Weight Gain
(Date:5/23/2013)... BRANFORD, Conn. , May 23, 2013  CAS Medical ... in medical devices for non-invasive patient monitoring, today announced that ... Executive Officer,  will present at the 2 nd Annual ... Grand Hyatt Hotel in New York City ... 1:30 p.m. ET in the Estate 10 room and will ...
(Date:5/23/2013)... NEW YORK , May 23, 2013  Intercept ... clinical stage biopharmaceutical company focused on the development and ... liver diseases, such as primary biliary cirrhosis, today announced ... and Chief Executive Officer, will present at the Deutsche ... Boston on Wednesday, May 29, 2013 ...
(Date:5/23/2013)... Calif. , May 23, 2013 Isis Pharmaceuticals, ... therapeutics, today announced that management will present a company overview ... Care Conference on Thursday, May 30, 2013 at 8:40 a.m. ... A live audio webcast of the presentation will be available ... site, www.isispharm.com .  A replay will be available on ...
Breaking Medicine Technology:CASMED to Present at the 2nd Annual Marcum MicroCap Conference 2Isis Pharmaceuticals to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference 2
... Anthera Pharmaceuticals,Inc., a privately-held biopharmaceutical company, ... of its first compound, A-002, for the ... that treatment with A-002,resulted in significant reductions ... Density Lipoprotein Cholesterol (non HDL-C), and Low ...
... Trial Reaffirms Primacy and Safety of ,First Generation, ... Genta,Incorporated (Nasdaq: GNTA ) announced the presentation ... its lead anticancer,compound, can be safely administered in ... new data were presented by Dr. Anthony Tolcher, ...
Cached Medicine Technology:Anthera Announces Positive Phase II Clinical Results From A-002 Cardiovascular Disease Trial 2Anthera Announces Positive Phase II Clinical Results From A-002 Cardiovascular Disease Trial 3Genasense(R) Can be Administered by Brief High-Dose IV Infusion 2Genasense(R) Can be Administered by Brief High-Dose IV Infusion 3Genasense(R) Can be Administered by Brief High-Dose IV Infusion 4
(Date:5/23/2013)... arch pulse wave velocity, a measure of arterial stiffness, ... vessels that supply blood to the brain, according to ... journal Radiology . , "Pulse wave velocity ... compliance that may help determine a patient,s risk for ... M.D., assistant professor of radiology at UT Southwestern Medical ...
(Date:5/23/2013)... 23, 2013 Applied PilotFish Healthcare ... that it has added support for the Direct Protocol ... eiConsole for Healthcare. In addition to the product’s already ... FTP, and Web Services, it now offers support for ... is a specification of the Direct Project ...
(Date:5/23/2013)... Elegance for a woman takes on so many different ... intrigue can often be found in the mystery of her eyes. ... is through her eyes. It is also true that that ... why the elegance of a woman can be found in her ... than any other time, utilize eyewear to not only compliment but ...
(Date:5/23/2013)... May 23, 2013 Aero Fulfillment Services, ... selected by NewWave Biosciences to be the sole fulfillment ... care professionals. , Brad Cole, CEO New Wave ... reasons including their central location, e-commerce experience with both ... and overall end-to-end solution that will expand as our ...
(Date:5/23/2013)... CA (PRWEB) May 23, 2013 Each month ... most innovative and stylish eco-friendly hybrids and electric cars. Nowhere ... in Los Angeles, the symbolic green car capital. Thankfully this ... Car Tour ride and drive back to Dwell on ... event. , During the first two days of Dwell ...
Breaking Medicine News(10 mins):Health News:MRI-based measurement helps predict vascular disease in the brain 2Health News:PilotFish Expand’s Healthcare Integration Capabilities with Support for the New Direct Protocol in Its Latest Product Release 2Health News:Dolabany Eyewear Adds Feminine Flare to Women's Designer Eyewear with 2013 New Release of Adelina by Best Image Optical, Inc. 2Health News:NewWave Biosciences Chooses Aero Fulfillment for e-Commerce Distribution of New Product to Reduce Inflammation 2Health News:Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013 2Health News:Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013 3Health News:Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013 4Health News:Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013 5
... ST-elevation myocardial infarction (STEMI) guidelines, protocols and standing ... labs has dramatically improved since 2003, according to ... the American College of Cardiology (ACC) Scientific Sessions ... Since the 1990s, the American College Cardiology (ACC)/American ...
... at the Queen Silvia Children,s Hospital has developed a method ... having a CT scan while still obtaining good image quality, ... is an advanced form of X-ray examination which generates images ... If the dose of radiation is lowered too far, however, ...
... Steven Reinberg HealthDay Reporter , MONDAY, April 4 ... failure because of blocked coronary arteries appear to fare as ... surgery or rely on medication alone, a new study seems ... found that bypass surgery does reduce the risk ...
... , MONDAY, April 4 (HealthDay News) -- People ... a new study suggests. It also found that a ... substance abuse and mood disorders. Researchers analyzed data from ... in the U.S. National Epidemiologic Survey of Alcohol and Related ...
... Alan Mozes HealthDay Reporter , MONDAY, April 4 ... a connection between listening to pop music and suffering from ... from your child,s MP3 player, know that the study did ... indication whether kids who were predisposed to depression were more ...
... in collaboration with researchers from Stony Brook University, has ... by 63 per cent. Shor reached these conclusions by ... (mainly western) countries, over the last 40 years. ... expectations that a better health-care system might contribute to ...
Cached Medicine News:Health News:Protocol-driven heart attack care proves effective and contagious 2Health News:Safer CT scanning for children developed at the Queen Silvia Children's Hospital 2Health News:Bypass Surgery Best for Some Heart Failure Patients 2Health News:Bypass Surgery Best for Some Heart Failure Patients 3Health News:Poverty Linked to Anxiety, Mood Disorders 2Health News:Could Pop Music Be Linked to Depression? 2Health News:Could Pop Music Be Linked to Depression? 3Health News:Men who lose their jobs at greater risk of dying prematurely 2
... IgG Test is an ELISA method for the ... viral capsid antigen (VCA) in human serum. When ... with other testing such as the EBV nuclear ... tests and/or heterophile tests, the results can serve ...
... (Lyme) test is an enzyme ... the qualitative detection of borrelia ... related Borrelia burgdorferi antibodies (IgG, ... in serum as an aid ...
The ImmunoWELL Borrelia (Lyme) Test is an enzyme immunoassay (EIA) for the qualitative and/or semiquantitative detection of Borrelia burgdorferi total antibodies (IgG, IgM, and IgA) in serum and is u...
The ImmunoWELL Thyroglobulin IgG Quantitative Test is a quantitative enzyme immunoassay (EIA) for screening and detection of autoantibodies against human thyroglobulin in serum and is used as an aid ...
Medicine Products: